After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved a new option for adult patients with tardive dyskinesia.
A recent meta-analysis sought to address this gap by examining studies that assessed the safety and efficacy of SSRIs and SNRIs in children with various psychiatric disorders.
After a review of existing data, the Endocrine Society has released several recommendations and statements regarding the treatment of symptoms associated with estrogen depletion following breast cancer.
...
A recent study investigated pharmacokinetic interactions between phosphodiesterase type 5 inhibitors and endothelin receptor antagonists used in combination for the treatment of pulmonary arterial...
A new drug candidate being developed to treat patients with chronic obstructive pulmonary disease would improve the delivery of medication to the lungs.
A study evaluated the frequency patients 65 years and older were prescribed 3 or more medications that affected the central nervous system between 2004 and 2013.
Chronic cluster headache is the most disabling form of cluster headache, and current treatment options are not very effective. For this study, researchers evaluated whether sphenopalatine ganglion...
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
Ivacaftor appears to be safe for young children with cystic fibrosis, though elevated liver function tests may call for increased monitoring, according to research from the KIWI study group.
